anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Monroes Sequence

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 33,236
Current window 21,061-21,090
Pages 1,108
Rows per page 30
Arc: Monroes Sequenceclear collectionreset all
18 30 60

Arc

21,061-21,090 of 33,236

filter-aware
05
OmniAb | Results Presentation Deck | 20 slidesOmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · Need1 hit
06
The chart shows a steady upward trend in the number of active partners.OmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · Satisfaction1 hit
07
The slide uses a logo grid to establish credibility through social proof.OmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · Satisfaction1 hit
08
The bar chart shows growth from 2016 to 2023; the pie chart shows the composition of the 305 active programs as of 06/30/2023.OmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · Satisfaction1 hit
09
OmniAb | Results Presentation Deck | 20 slidesOmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · Satisfaction1 hit
10
OmniAb | Results Presentation Deck | 20 slidesOmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
OmniAb | Results Presentation Deck | 20 slidesOmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
Includes a radial phylogenetic-style diagram of ion channel targets.OmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
13
The slide uses a two-tier structure: top tier for operational focus areas and bottom tier for stakeholder engagement.OmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
14
OmniAb | Results Presentation Deck | 20 slidesOmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · Satisfaction1 hit
15
The table displays variance between two quarters in millions of dollars.OmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
16
OmniAb | Results Presentation Deck | 20 slidesOmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
17
The table displays financial performance over six quarters, highlighting significant fluctuations in revenue and operating losses.OmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · Satisfaction1 hit
18
OmniAb | Results Presentation Deck | 20 slidesOmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · Action1 hit
19
The slide uses a Gantt-style visualization to show the progress of drug programs through clinical phases.OmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · Action1 hit
20
OmniAb | Results Presentation Deck | 20 slidesOmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Theravance Biopharma | Results Presentation Deck | 35 slidesTheravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Attention1 hit
02
Theravance Biopharma | Results Presentation Deck | 35 slidesTheravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Attention1 hit
03
Theravance Biopharma | Results Presentation Deck | 35 slidesTheravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses a three-column layout to categorize strategic priorities.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Attention1 hit
05
Theravance Biopharma | Results Presentation Deck | 35 slidesTheravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Attention1 hit
06
Slide serves as a product introduction/cover slide for a corporate presentation.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Need1 hit
07
Theravance Biopharma | Results Presentation Deck | 35 slidesTheravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Need1 hit
08
The slide shows two line charts tracking market share growth in different care settings.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Need1 hit
09
The slide highlights consistent growth in both metrics, with Q/Q growth percentages annotated above each bar.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Need1 hit
10
Uses a Venn diagram to illustrate the patient segments (Dexterity Challenges, Cognitive Impairment, Suboptimal PIFR) that define the addressable population.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
11
Theravance Biopharma | Results Presentation Deck | 35 slidesTheravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
The slide outlines a clinical trial methodology using a timeline-based study design.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
13
The slide illustrates how findings from one study (PIFR-1) informed the design of a subsequent study (PIFR-2) by narrowing the patient population to GOLD 3/4, resulting in statistically significant improvement.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
14
Theravance Biopharma | Results Presentation Deck | 35 slidesTheravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit